Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1998-06-26
2000-09-05
Salimi, Ali
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241991, 4353201, 4352351, 435325, 435 691, A61K 39235, A61K 3912, C12N 700, C12N 701, C12N 1500
Patent
active
061139130
ABSTRACT:
The present invention provides a recombinant adenovirus having a genome with a deficiency in the E1 region and a mutation in the MLP. The invention also provides stocks of such viruses and compositions including the inventive viruses. The invention also provides cell lines for propagating the recombinant adenoviruses.
REFERENCES:
patent: 4510245 (1985-04-01), Cousens et al.
patent: 5474935 (1995-12-01), Chatterjee et al.
Amalfitano et al. Proc. Natl. Acad. Sci. USA, 93, pp. 3352-3356 (1996).
Amalfitano et al. Gene Therapy, 4,pp. 258-263 (1997).
Amalfitano et al. Journal of Virology, 72(2), pp. 926-933 (1998).
Brunet et al. Molecular and Cellular Biology, 7(3), pp. 1091-1100 (1987).
Chodosh et al. Molecular and Cellular Biology, 6(12),pp. 4723-4733 (1986).
Gustin et al. Journal of Virology, 70(9), pp. 6463-6467 (1996).
Kubo et al. Gene, 153, pp. 279-280 (1995).
Loh et al. Journal of Biological Chemistry, 271(18), pp. 10884-10891 (1996).
Lu et al. Journal of Virology, 71(1), pp. 102-109 (1997).
Lutz et al. Journal of Virology, 70(3), pp. 1396-1405 (1996).
Lutz et al. Journal of Virology, 70(6), pp. 3449-3460 (1996).
Manohar et al. Journal of Virology, 64(6), pp. 2457-2466 (1990).
Miyamoto et al. The EMBO Journal, 4(13A), pp. 4563-3570 (1985).
Perlmutter et al. Clinical and Experimental Pharmacology and Physiology, 17, pp. 697-706 (1990).
Reach et al. Journal of Virology, 64(12), pp. 5851-5860 (1990).
Reach et al. The EMBO Journal, 10(11), pp. 3439-3446 (1991).
Sawadago et al. Cell, 43, pp. 165-175 (1985).
Schaack et al. Journal of Virology, 69(7), pp. 4079-4085 (1995).
Song et al. Virology, 220(2), pp. 390-401 (1996).
Strubin et al. Cell, 68, pp. 721-730 (1992).
Tribouley et al. Journal of Virology, 68(7), pp. 4450-4457 (1994).
Van Beveren et al. Gene, pp. 179-189 (1981).
Wilkinson et al. Nucleic Acids Research, 20(9), pp. 2233-2239 (1992).
Wu et al. Biotechniques, 21, pp. 718-725 (1996).
Lieber et al., Journal of Virology, 70 (12), 8944-8690 (1996).
Tansey et al., Science, 275 (5301), 829-831 (1997).
Yang et al., PNAS USA, 91 (10), 4407-4411 (1994).
Brough Douglas E.
Kovesdi Imre
GenVec, Inc.
Salimi Ali
LandOfFree
Recombinant adenovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant adenovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant adenovirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2209263